Penile squamous cell carcinoma (PSCC) is a rare cancer, but is more common in developing countries. Locally advanced and metastatic PSCC is associated with significant morbidity and mortality, with the prognosis remaining extremely poor. The authors searched PubMed and published abstracts for metastatic PSCC studies to describe emerging therapies. Multimodality treatment using chemotherapy, radiation, and consolidative surgery are standard of care. Utilizing anti-EGFR therapies and novel immunotheraputic approaches may help improve outcomes in PSCC.
|Original language||English (US)|
|Number of pages||11|
|Journal||Urologic Clinics of North America|
|State||Published - Nov 1 2016|
Bibliographical notePublisher Copyright:
© 2016 Elsevier Inc.
- Combined modality therapy
- Penile squamous cell carcinoma
- Targeted therapy